A Randomized Double-blind Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
Brief description of study
see synopsis
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
epilepsy,seizure
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
29 May 2023.
Study ID: 832213